The Promise and Perils of Biotech in Personalised Healthcare. Can New Regulatory Pathways Protect the Vulnerable?

Risk and Regulation Magazine 32 (Winter 2018):20-23 (2018)
Download Edit this record How to cite View on PhilPapers
The paper discusses some of the implications of regulatory innovation in the area of advanced biological therapies and personalised medicine. Benefits, risks and trade-offs are highlighted.
PhilPapers/Archive ID
Upload history
Archival date: 2019-04-01
View other versions
Added to PP index

Total views
47 ( #52,012 of 2,427,498 )

Recent downloads (6 months)
4 ( #57,570 of 2,427,498 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.